1st Committee to Discuss Approval of New Products Including Janssen’s Extended Release Schizophrenia Treatment

July 23, 2013
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on Drugs, an advisory organ to the health minister, will discuss whether to approve a number of products including Janssen Pharmaceutical’s schizophrenia treatment paliperidone palmitate, a long acting injectable formulation,...read more